1. Home
  2. WEAV vs MPLT Comparison

WEAV vs MPLT Comparison

Compare WEAV & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$6.75

Market Cap

507.2M

Sector

Technology

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc. Common Stock

N/A

Current Price

$20.41

Market Cap

594.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEAV
MPLT
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.2M
594.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
WEAV
MPLT
Price
$6.75
$20.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$12.20
$31.00
AVG Volume (30 Days)
1.5M
260.1K
Earning Date
10-30-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$229,790,000.00
N/A
Revenue This Year
$19.19
N/A
Revenue Next Year
$15.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.34
N/A
52 Week Low
$5.64
$12.24
52 Week High
$17.63
$21.00

Technical Indicators

Market Signals
Indicator
WEAV
MPLT
Relative Strength Index (RSI) 59.97 N/A
Support Level $6.23 N/A
Resistance Level $6.61 N/A
Average True Range (ATR) 0.22 0.00
MACD 0.09 0.00
Stochastic Oscillator 95.02 0.00

Price Performance

Historical Comparison
WEAV
MPLT

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About MPLT MapLight Therapeutics Inc. Common Stock

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: